Bio-Thera & Dr Reddy’s execute commercialization pact for biosimilars Stelara & Simponi for SE Asia
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506
Omega 3 oil 18 EPA/12 DHA is highly demanded worldwide for its multiple benefits for human and animal health
The freshly infused capital will primarily be deployed towards expansion and research & development
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
The products will be manufactured in Goa India and marketed & distributed in Australian markets
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Nanomi's pioneering approach in drug delivery has set new benchmarks in the industry, and this award serves as a motivation to continue its mission to revolutionize healthcare
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), will be distributed in the US by Glenmark Therapeutics, USA.
Subscribe To Our Newsletter & Stay Updated